Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Valagussa

Showing results (111-120 of 196) with videos related to

Pageof 20
Sort By:
Breast Cancer Research and Treatment|May 1, 1990
Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapyP Valagussa, M Zambetti, G Bonadonna, et al.
Seminars in Oncology|March 20, 2001
Adjuvant and neoadjuvant treatment of breast cancerL Gianni, P Valagussa, M Zambetti, et al.
Breast Cancer Research and Treatment|January 1, 1981
Adjuvant CMF effect on site of first recurrence, and appropriate follow-up intervals, in operable breast cancer with positive axillary nodesP Valagussa, J D Tess, A Rossi, et al.
The American Journal of Medicine|September 1, 1987
Adjuvant chemotherapy after conservative surgery plus irradiation versus modified radical mastectomy. Analysis of drug dosing and toxicityR B Weiss, P Valagussa, A Moliterni, et al.
Blood|March 1, 1982
Absence of treatment-induced second neoplasms after ABVD in Hodgkin's diseaseP Valagussa, A Santoro, F Fossati Bellani, et al.
Cancer Treatment Reports|April 1, 1987
Cell kinetics as a prognostic marker in locally advanced breast cancerR Silvestrini, M G Daidone, P Valagussa, et al.
American Journal of Clinical Oncology|February 1, 1996
Intermediate doses of cyclophosphamide alone or following adriamycin in advanced breast cancer. A pilot studyM Zambetti, M Terenziani, C Bartoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer InstituteG Bonadonna, P Valagussa, C Brambilla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1994
Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's diseaseL Devizzi, A Santoro, V Bonfante, et al.
Breast Cancer Research and Treatment|January 1, 1986
Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancerR Silvestrini, M G Daidone, G Di Fronzo, et al.
Pageof 20

Showing results (111-120 of 196) with videos related to

Sort By:
Pageof 20
Breast Cancer Research and Treatment|May 1, 1990
Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapyP Valagussa, M Zambetti, G Bonadonna, et al.
Seminars in Oncology|March 20, 2001
Adjuvant and neoadjuvant treatment of breast cancerL Gianni, P Valagussa, M Zambetti, et al.
Breast Cancer Research and Treatment|January 1, 1981
Adjuvant CMF effect on site of first recurrence, and appropriate follow-up intervals, in operable breast cancer with positive axillary nodesP Valagussa, J D Tess, A Rossi, et al.
The American Journal of Medicine|September 1, 1987
Adjuvant chemotherapy after conservative surgery plus irradiation versus modified radical mastectomy. Analysis of drug dosing and toxicityR B Weiss, P Valagussa, A Moliterni, et al.
Blood|March 1, 1982
Absence of treatment-induced second neoplasms after ABVD in Hodgkin's diseaseP Valagussa, A Santoro, F Fossati Bellani, et al.
Cancer Treatment Reports|April 1, 1987
Cell kinetics as a prognostic marker in locally advanced breast cancerR Silvestrini, M G Daidone, P Valagussa, et al.
American Journal of Clinical Oncology|February 1, 1996
Intermediate doses of cyclophosphamide alone or following adriamycin in advanced breast cancer. A pilot studyM Zambetti, M Terenziani, C Bartoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer InstituteG Bonadonna, P Valagussa, C Brambilla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1994
Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's diseaseL Devizzi, A Santoro, V Bonfante, et al.
Breast Cancer Research and Treatment|January 1, 1986
Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancerR Silvestrini, M G Daidone, G Di Fronzo, et al.
Pageof 20